Jane Sarashon

MAY 22, 2023

As patients continue to morph into health consumers, facing rising out-of-pocket costs for deductibles and coinsurance shares, people are healthcare payers alongside their employers and government sponsors for insurance. For context, check out the third chart I’m sharing here from a recent survey into U.S.

Patient Advocacy 52

Patient Advocacy FDA Hospitals Doctors 52

The Digital Health Corner

NOVEMBER 28, 2016

Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies, ubiquity of mobile devices, proliferation of technology incubators, attention by government health and regulatory agencies and involvement of large companies heretofore not focused on healthcare.

Public Health 68

Public Health Health Services Administration Patient Advocacy Governance 68

HIT Consultant

FEBRUARY 22, 2023

Andrew Barnhill, Head of Public Policy, Global Legal, IQVIA Alexandra Weiss, Director of Strategic Partnerships, Patient Advocacy Organizations, IQVIA Diversity is paramount to the success of clinical research, both ethically and scientifically.

Patient Advocacy 98

Patient Advocacy Health Insurance FDA Governance 98

Health Populi

JANUARY 29, 2019

Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. The increased use of real-world evidence (RWE) and patient involvement in clinical trials. The first FDA cleared DTx was reSET from Pear Therapeutics, cleared in November 2018. using consumer-generated technology.

Prescription Drug Pricing 101

Prescription Drug Pricing FDA Patient Advocacy Governance 101

Health Law Advisor

JULY 21, 2023

Food and Drug Administration (FDA) as breakthrough devices. [1] 5] However, devices in earlier stages of the FDA approval process often lack the clinical evidence needed to satisfy the “reasonable and necessary” criteria to justify CMS’s establishment of a national coverage standard.

FDA 52

FDA Medicare Medicare Patient Advocacy 52